AQST EPS Estimates
Aquestive Therapeutics, Inc.
$4.61
-$0.06(-1.28%)
50
Overall
40
Value
60
Tech
52
Quality
Market Cap
$578.61M
Volume
1.60M
52W Range
$2.93 - $7.55
Target Price
$9.22
AQST EPS estimates: the consensus estimate for Aquestive Therapeutics, Inc.'s current fiscal year is -$0.50 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AQST EPS Estimates
- EPS estimate, current quarter
- $-0.10
- EPS estimate, next quarter
- $-0.11
- EPS estimate, current year
- $-0.50
- EPS estimate, next year
- $-0.50
- EPS growth, 3-year
- +11.36%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.78 |
| 2024 | $-0.51 |
| 2023 | $-0.13 |
| 2022 | $-1.12 |
| 2021 | $-1.85 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AQST | $4.61 | -1.3% | 1.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aquestive Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW